Ratio karoo amine slice and preparing technique thereof

A kind of bicalutamide tablet, the technology of bicalutamide, be applied in the field of bicalutamide tablet and preparation technology

Inactive Publication Date: 2008-06-18
SHANGHAI FOSUN PHARMA (GROUP) CO LTD +1
View PDF0 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

No other significant effects in general pharmacological tests

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Ratio karoo amine slice and preparing technique thereof
  • Ratio karoo amine slice and preparing technique thereof
  • Ratio karoo amine slice and preparing technique thereof

Examples

Experimental program
Comparison scheme
Effect test

example 1-3

[0063] Example of Bicalutamide Tablets (1000 Tablets)

[0064]

[0065] Operation process:

[0066] 1. Bicalutamide is micronized (below 25um), and the excipients are passed through a 100-mesh sieve.

[0067] 2. Weigh the prescribed amount of bicalutamide, lactose, and sodium carboxymethyl starch.

[0068] 3. Put the prescribed amount of bicalutamide, lactose, and sodium carboxymethyl starch into a high-speed wet granulator, stir at a low speed for 3 minutes, stir at a high speed for 2 minutes, add 2% HPMC aqueous solution to granulate, and stir at a low speed (120 rpm) for 3 minutes .

[0069] 4. Ventilate and dry at 65-75°C for 1-2 hours, and sieve with 16 meshes for granulation.

[0070] 5. Add the prescribed amount of magnesium stearate, mix for 50 turns (15 minutes), and take samples to determine the content and moisture of the intermediate.

[0071] 6. According to the determination result of the intermediate content, the weight of the plain tablet is calculated a...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a bicalutamide tablet and the related preparation process. The invention adopts new tablet formula and new technique and overcomes the shortcomings in prior art. The technique of the invention is favorable for scale-type industrial production and the product is improved in quality and is good in dissolution.

Description

Technical field: [0001] The invention belongs to the technical field of pharmaceutical preparations. It specifically relates to bicalutamide tablets and a preparation process. Background technique: [0002] Prostate cancer is currently the most common malignant tumor in men, ranking second in incidence. At present, the main clinical treatment methods include surgical castration, estrogen therapy and luteinizing hormone analog therapy. However, due to the refractoriness of some patients to hormone therapy, relapse often occurs within 18 to 24 months after treatment, and is related to the later life of the patient. Therefore, it is very necessary to find potent and longer-lasting therapeutic drugs. [0003] Bicalutamide is a pure antiandrogen with no other endocrine activity. There are no other significant effects in general pharmacological tests. In long-term dosing studies, dogs at doses greater than ED with prostate atrophy 50 When the value is 25 times, it causes mil...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/20A61K31/167A61P35/00A61P13/08
Inventor 熊洁包玉林蔡胜
Owner SHANGHAI FOSUN PHARMA (GROUP) CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap